FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias - PubMed (original) (raw)
FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias
P Krejcí et al. Leukemia. 2001 Feb.
Abstract
An elevated level of fibroblast growth factor-2 (FGF-2) in peripheral blood is considered to play a role in regulating the growth of leukemia cells. Here, we show that the level of plasma FGF-2 is increased in 54% of B cell chronic lymphocytic leukemias (B-CLL) and in 44% of chronic myeloid leukemias (CML). Notably, white blood cells (WBCs) from B-CLL patients contain 18, 22 and 24 kDa isoforms of FGF-2 whereas WBCs from CML patients contain only the 24 kDa isoform. Furthermore, as cultured B-CLL WBCs release 18 kDa FGF-2 into the medium, they constitute a potential source of FGF-2 in the blood. In a receptor binding assay, 125I-FGF-2 binds weakly to B-CLL WBCs, whereas the ligand binds more strongly to CML WBCs. Correspondingly, FGF-2 is unable to activate mitogen-activated protein kinase kinase (MEK) and its substrate, extracellular signal-regulated kinase (ERK), in B-CLL cells, whereas phosphorylation of both these cell growth-related kinases increases following treatment of CML WBCs. We conclude that B-CLL WBCs secrete FGF-2 with no apparent autocrine actions. In contrast, WBCs in CML bind FGF-2 provided by other FGF-2-hyperproducing cells and activate the MEK/ERK kinase cascade, possibly to modulate cell growth.
Similar articles
- The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.
Crişan AM, BădeliŢă SN, Jardan C, Vasilache ED, Dobrea CM, Gheorghe A, Tălmaci R, Arion CV, Bardaş A, Găman AM, Coriu D. Crişan AM, et al. Rom J Morphol Embryol. 2015;56(3):1145-51. Rom J Morphol Embryol. 2015. PMID: 26662151 Review. - [Chronic lymphocytic and myeloid leukemia in the same patient].
Gregersen H, Drewes AM, Asschenfeldt PB, Laursen JC. Gregersen H, et al. Ugeskr Laeger. 1995 Nov 6;157(45):6274-5. Ugeskr Laeger. 1995. PMID: 7491723 Danish. - Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS, Jobe DA, Asp KE, Callister SM, Mathiason MA, Meyer LA, Bottner WA, Cole CE, Farnen JP, Frisby KA. Go RS, et al. Ann Hematol. 2008 May;87(5):369-73. doi: 10.1007/s00277-007-0435-y. Epub 2008 Jan 12. Ann Hematol. 2008. PMID: 18193423 - [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H, Kuwayama M, Kotake T, Karasuno T. Hattori H, et al. Gan To Kagaku Ryoho. 2011 Feb;38(2):333-6. Gan To Kagaku Ryoho. 2011. PMID: 21368508 Review. Japanese. - Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M, Kusenda J, Babusíková O. Klobusická M, et al. Neoplasma. 2003;50(6):408-15. Neoplasma. 2003. PMID: 14689061
Cited by
- HnRNPK maintains single strand RNA through controlling double-strand RNA in mammalian cells.
Mahale S, Setia M, Prajapati B, Subhash S, Yadav MP, Thankaswamy Kosalai S, Deshpande A, Kuchlyan J, Di Marco M, Westerlund F, Wilhelmsson LM, Kanduri C, Kanduri M. Mahale S, et al. Nat Commun. 2022 Aug 29;13(1):4865. doi: 10.1038/s41467-022-32537-0. Nat Commun. 2022. PMID: 36038571 Free PMC article. - Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases.
Zou YX, Qiao J, Zhu HY, Lu RN, Xia Y, Cao L, Wu W, Jin H, Liu WJ, Liang JH, Wu JZ, Wang L, Fan L, Xu W, Li JY. Zou YX, et al. Cancer Res Treat. 2019 Apr;51(2):664-671. doi: 10.4143/crt.2018.358. Epub 2018 Aug 1. Cancer Res Treat. 2019. PMID: 30064197 Free PMC article. - Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, Gliksman M, Goy A, Suh KS. Akl MR, et al. Oncotarget. 2016 Jul 12;7(28):44735-44762. doi: 10.18632/oncotarget.8203. Oncotarget. 2016. PMID: 27007053 Free PMC article. Review. - Critical signal transduction pathways in CLL.
Ghosh AK, Kay NE. Ghosh AK, et al. Adv Exp Med Biol. 2013;792:215-39. doi: 10.1007/978-1-4614-8051-8_10. Adv Exp Med Biol. 2013. PMID: 24014299 Free PMC article. Review. - P7 peptides suppress the proliferation of K562 cells induced by basic fibroblast growth factor.
Wang C, Yu Y, Li Q, Gao S, Jia X, Chen X, Wang R, Li T, Wang W, Li X, Wu X. Wang C, et al. Tumour Biol. 2012 Aug;33(4):1085-93. doi: 10.1007/s13277-012-0348-9. Epub 2012 Feb 21. Tumour Biol. 2012. PMID: 22351562
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous